South Korea: Agricultural Biotechnology Annual
Link to report:
Korea is in the process of revising its Living Modified Organism (LMO) Act. Once completed, these revisions will define Korea’s regulatory policies for products that utilize innovative technologies, including genome editing. Finalized changes to the LMO Act are expected by the end of 2022 with implementation planned for the end of 2023. Additionally, Korea has announced mandatory biotech labeling will be required for all products containing biotech ingredients beginning in 2026.
